Literature DB >> 3038318

Phase II trial of oral piritrexim (BW301U) in patients with stage III non-small cell lung cancer.

M G Kris, R J Gralla, M T Burke, L D Berkowitz, L D Marks, D P Kelsen, R T Heelan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3038318

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  3 in total

Review 1.  From methotrexate to pemetrexed and beyond. A review of the pharmacodynamic and clinical properties of antifolates.

Authors:  Jackie Walling
Journal:  Invest New Drugs       Date:  2006-01       Impact factor: 3.651

2.  A phase II and pharmacokinetic study with oral piritrexim for metastatic breast cancer.

Authors:  E G de Vries; J A Gietema; P Workman; J E Scott; A Crawshaw; H J Dobbs; I Dennis; N H Mulder; D T Sleijfer; P H Willemse
Journal:  Br J Cancer       Date:  1993-09       Impact factor: 7.640

3.  A phase II study of oral piritrexim in recurrent high-grade (III, IV) glioma.

Authors:  N M Bleehen; H V Newman; R P Rampling; J R Ramsay; J T Roberts; P Bedford; A B Nethersell
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.